While reporting financial results for the second quarter, generic pharmaceutical company Akorn, Inc. (AKRX) on Thursday widened its net loss guidance for the full-year 2019, while affirming net revenue outlook.
from RTT - Earnings https://ift.tt/2OyWy22
via IFTTT
No comments:
Post a Comment